CA-242 ANTIGEN - ANVISA Registration 80102513425
Access comprehensive regulatory information for CA-242 ANTIGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80102513425 and manufactured by AUTOBIO DIAGNOSTICS CO., LTD. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until May 12, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80102513425
25351451954202411
04718143000194
Company Information
Dates and Status
May 12, 2025
12/05/2035
09/18/2025 19:00:01
CA-242 ANTIGEN
FAMILIA MAGLUMI CA 242 (CLIA)
Not specified
80102512957
Feb 13, 2023
CA-242 ANTIGEN
FAMILIA MAGLUMI CA 242 (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102512957
Feb 13, 2023
CA 125 ANTIGEN
Família AutoLumo Micropartículas de CA125 (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513429
May 19, 2025
CA 125 ANTIGEN
Família AutoLumo Micropartículas de CA125 (CLIA)
Not specified
80102513429
May 19, 2025
CA 72-4 ANTIGEN
Família AutoLumo CA72-4 Micropartículas (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513442
Jun 09, 2025
ANTÍGENO CA-242
FAMILIA MAGLUMI CA 242 (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102512957
Feb 13, 2023
ANTÍGENO CA-242
FAMILIA MAGLUMI CA 242 (CLIA)
Not specified
80102512957
Feb 13, 2023